Lynx1 Capital Management Lp

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Pieris Pharmaceuticals, Inc.
PIRS
$1.61B664.978.78M-10.2%-$182.59M84.78
TScan Therapeutics, Inc.
TCRX
$41.48M9.885.22M0%+$02.19
Passage Bio, Inc.
PASG
$6.54M7.864.85M+1,178.06%+$6.03M0.35
Stoke Therapeutics, Inc.
STOK
$49.91M7.093.7M+25.02%+$9.99M2.63
GH Research PLC
GHRS
$35.29M6.363.31M+80.06%+$15.69M1.86
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.